EUVIMEDEUVIMED entdecken
Kommentar

RESOLVE to do better

Jane A Little iD

British Journal of Haematology · 2026-11 · 209 (5) · 2389-2391

DOI: 10.1111/bjh.70857 ↗

Kurz gefasst

Kommentar in der Zeitschrift British Journal of Haematology, online erschienen am 27.09.2026. Verfasst von Jane A Little. Beteiligte Einrichtung: Adult Sickle Cell Disease Clinic at University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Leg Ulcer. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Commentary on: Long Title: Phase 3, randomised, placebo‐controlled trial of Voxelotor for the resolution of leg ulcers in sickle cell disease: RESOLVE. Br J Haematol. 2026;209:2252–2263.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellLeg UlcerHumansRandomized Controlled Trials as TopicClinical Trials, Phase III as TopicBenzaldehydesPyrazinesPyrazoles

Stichwörter der Autor:innen

hemolytic anemianovel therapiessickle cell disease

Substanzen

voxelotorBenzaldehydesPyrazinesPyrazoles

Autor:innen und Institutionen

  • Adult Sickle Cell Disease Clinic at University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA.
  • UNC Blood Research Center, Chapel Hill, North Carolina, USA.

ORCID-Profile: Jane A Little

Zitieren

APA

Little, J. A. (2026). RESOLVE to do better. British Journal of Haematology, 209(5), 2389-2391. https://doi.org/10.1111/bjh.70857

Vancouver

Little JA. RESOLVE to do better. British Journal of Haematology. 2026;209(5):2389-2391. doi:10.1111/bjh.70857

BibTeX
@article{Little2026,
  author = {Little, Jane A},
  title = {RESOLVE to do better},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {209},
  number = {5},
  pages = {2389--2391},
  doi = {10.1111/bjh.70857}
}
Kostenlos starten →